scholarly article | Q13442814 |
P50 | author | Patrick J. Farmer | Q40477908 |
Thomas W Miller | Q57040605 | ||
Adrian J Hobbs | Q57077668 | ||
P2093 | author name string | Jon M Fukuto | |
S Bruce King | |||
Katrina M Miranda | |||
Judith N Burstyn | |||
Andrea J Lee | |||
Melisa M Cherney | |||
Nestor E Francoleon | |||
P2860 | cites work | Guanylate cyclase and the .NO/cGMP signaling pathway | Q28143751 |
Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion | Q28361019 | ||
Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt | Q28361038 | ||
Hydrolysis of Acyloxy Nitroso Compounds Yields Nitroxyl (HNO) | Q29397120 | ||
Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide | Q31062804 | ||
On the acidity and reactivity of HNO in aqueous solution and biological systems | Q34445763 | ||
Nitroxyl gets to the heart of the matter. | Q34981557 | ||
Positive inotropic and lusitropic effects of HNO/NO − in failing hearts: Independence from β-adrenergic signaling | Q34983537 | ||
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels | Q35009484 | ||
Spectral and ligand-binding properties of an unusual hemoprotein, the ferric form of soluble guanylate cyclase | Q71010153 | ||
Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase | Q71209999 | ||
Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate t | Q72183771 | ||
Reversible inactivation of guanylate cyclase by mixed disulfide formation | Q72457078 | ||
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates | Q72488009 | ||
Bioassay discrimination between nitric oxide (NO.) and nitroxyl (NO-) using L-cysteine | Q72488285 | ||
Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung | Q72538837 | ||
Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme | Q72539436 | ||
Requirement for heme in the activation of purified guanylate cyclase by nitric oxide | Q72555070 | ||
Electron paramagnetic resonance spectral evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase | Q72566480 | ||
Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO | Q72607660 | ||
Identification and partial purification of an endogenous inhibitor of soluble guanylyl cyclase from bovine lung | Q72678836 | ||
Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide | Q77134104 | ||
Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase | Q77501939 | ||
The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature | Q79451723 | ||
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae | Q79798643 | ||
Effect of nitroxyl on human platelets function | Q81438726 | ||
Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta | Q35041842 | ||
A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system | Q35234291 | ||
Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation | Q35925811 | ||
Coordination chemistry of the HNO ligand with hemes and synthetic coordination complexes | Q35983739 | ||
Activation of purified soluble guanylate cyclase by protoporphyrin IX. | Q36293899 | ||
The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO | Q36408421 | ||
Soluble guanylate cyclase | Q36610123 | ||
Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction | Q36905844 | ||
Activation of hepatic guanylate cyclase by N-methyl-N'-nitro-N-nitrosoguanidine. Effects of thiols, N-ethylmaleimide, and divalent cations | Q39155731 | ||
Oxidative-reductive modulation of guinea pig splenic cell guanylate cyclase activity | Q39188716 | ||
Effects of thiol inhibitors on hepatic guanylate cylase activity | Q39195101 | ||
Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide | Q39969381 | ||
Nitric oxide-cyclic GMP signal transduction system. | Q41100343 | ||
Calcium ion downregulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism | Q43614080 | ||
Photolysis of the HNO adduct of myoglobin: transient generation of the aminoxyl radical | Q43693272 | ||
Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed. | Q43800978 | ||
Role of catalase in the smooth muscle relaxant actions of sodium azide and cyanamide. | Q43854038 | ||
1H NMR structure of the heme pocket of HNO-myoglobin | Q44317568 | ||
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries | Q44438485 | ||
Preparation of heme-free soluble guanylate cyclase | Q44577972 | ||
Fast nitroxyl trapping by ferric porphyrins. | Q44685929 | ||
Efficient trapping of HNO by deoxymyoglobin | Q44744397 | ||
Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. | Q45946745 | ||
Antioxidant actions of nitroxyl (HNO). | Q45996374 | ||
Bonding in HNO-myoglobin as characterized by X-ray absorption and resonance raman spectroscopies. | Q46336986 | ||
Nitric oxide-related species-induced protein oxidation: reversible, irreversible, and protective effects on enzyme function of papain. | Q46394502 | ||
Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines | Q46756652 | ||
Mechanisms of HNO and NO production from Angeli's salt: density functional and CBS-QB3 theory predictions | Q46781301 | ||
Theoretical reduction potentials for nitrogen oxides from CBS-QB3 energetics and (C)PCM solvation calculations | Q46810248 | ||
Characterization of nitrosoalkane binding and activation of soluble guanylate cyclase | Q46838730 | ||
Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo | Q46860343 | ||
Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation | Q51696392 | ||
Electromagnetic properties of hemoproteins. V. Optical and electron paramagnetic resonance characteristics of nitric oxide derivatives of metalloporphyrin-apohemoprotein complexes. | Q54332403 | ||
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects | Q68064574 | ||
Oxidation of dithiothreitol during turnover of nitric oxide reductase: evidence for generation of nitroxyl with the enzyme from Paracoccus denitrificans | Q68099225 | ||
Stereochemistry of low-spin cobalt porphyrins. I. Structure and bonding in a nitrosylcobalt porphyrin and their bearing on one rational model for the oxygenated protoheme | Q69645941 | ||
Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms | Q69878955 | ||
The involvement of catalytic site thiol groups in the activation of soluble guanylate cyclase by sodium nitroprusside | Q69892443 | ||
P433 | issue | 33 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 9 | |
P304 | page(s) | 21788-21796 | |
P577 | publication date | 2009-06-15 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols | |
P478 | volume | 284 |
Q64927542 | A Mononuclear, Nonheme FeII-Piloty's Acid (PhSO2NHOH) Adduct: An Intermediate in the Production of {FeNO}7/8 Complexes from Piloty's Acid. |
Q88956991 | A recent history of nitroxyl chemistry, pharmacology and therapeutic potential |
Q34586679 | Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties |
Q28391506 | Basic principles and emerging concepts in the redox control of transcription factors |
Q36376440 | Biological signaling by small inorganic molecules |
Q37412845 | Cardiovascular consequences when nitric oxide and lipid signaling converge |
Q38055957 | Computational investigations of HNO in biology. |
Q42681487 | Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C. |
Q34622608 | Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors. |
Q43755565 | HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO. |
Q52373697 | Hemodynamic Effects of Glutathione-Liganded Binuclear Dinitrosyl Iron Complex: Evidence for Nitroxyl Generation and Modulation by Plasma Albumin. |
Q50763935 | Mechanistic studies of the reactions of the reduced vitamin B12 derivatives with the HNO donor Piloty's acid: further evidence for oxidation of cob(I)alamin by (H)NO. |
Q41896679 | Metal centre effects on HNO binding in porphyrins and the electronic origin: metal's electronic configuration, position in the periodic table, and oxidation state |
Q36011399 | New acyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q39425650 | Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1. |
Q38224809 | Nitroxyl (HNO) for treatment of acute heart failure |
Q34233761 | Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation |
Q39995085 | Nitroxyl as a ligand in ruthenium tetraammine systems: a density functional theory study |
Q33925515 | Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway |
Q41565976 | Oxidant sensor in the cGMP-binding pocket of PKGIα regulates nitroxyl-mediated kinase activity. |
Q36573243 | Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects. |
Q34030551 | Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects. |
Q37010822 | Recent advances in the chemical biology of nitroxyl (HNO) detection and generation |
Q42361109 | Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide |
Q30412936 | S-Nitrosylation signaling regulates cellular protein interactions |
Q33771832 | Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species |
Q38935734 | The chemical biology of HNO signaling |
Q35040403 | The chemistry of nitroxyl-releasing compounds |
Q42365805 | The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain |
Q34756677 | The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems. |
Q38827338 | Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure |
Q37588783 | Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor |
Q46434234 | Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes |
Q42403629 | Water soluble acyloxy nitroso compounds: HNO release and reactions with heme and thiol containing proteins |
Search more.